Annual ROA
-25.10%
+9.46%+27.37%
December 1, 2024
Summary
- As of March 10, 2025, CLDX annual return on assets is -25.10%, with the most recent change of +9.46% (+27.37%) on December 1, 2024.
- During the last 3 years, CLDX annual ROA has fallen by -4.38% (-21.14%).
- CLDX annual ROA is now -1142.57% below its all-time high of -2.02%, reached on December 31, 2010.
Performance
CLDX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-20.80%
+2.66%+11.34%
December 1, 2024
Summary
- As of March 10, 2025, CLDX quarterly return on assets is -20.80%, with the most recent change of +2.66% (+11.34%) on December 1, 2024.
- Over the past year, CLDX quarterly ROA has stayed the same.
- CLDX quarterly ROA is now -909.71% below its all-time high of -2.06%, reached on December 31, 2010.
Performance
CLDX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
CLDX ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.4% | 0.0% |
| 3 y3 years | -21.1% | 0.0% |
| 5 y5 years | +31.3% | 0.0% |
CLDX ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.1% | +27.4% | at high | +49.3% |
| 5 y | 5-year | -21.1% | +31.3% | at high | +49.3% |
| alltime | all time | -1142.6% | +92.1% | -909.7% | +94.5% |
Celldex Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -25.10%(-27.4%) | -20.80%(-11.3%) |
| Sep 2024 | - | -23.46%(-13.8%) |
| Jun 2024 | - | -27.22%(-15.9%) |
| Mar 2024 | - | -32.36%(-21.2%) |
| Dec 2023 | -34.56%(+22.7%) | -41.05%(+7.1%) |
| Sep 2023 | - | -38.32%(+18.5%) |
| Jun 2023 | - | -32.35%(+2.2%) |
| Mar 2023 | - | -31.66%(+12.4%) |
| Dec 2022 | -28.17%(+36.0%) | -28.17%(+11.7%) |
| Sep 2022 | - | -25.22%(-2.0%) |
| Jun 2022 | - | -25.73%(+17.1%) |
| Mar 2022 | - | -21.98%(-2.5%) |
| Dec 2021 | -20.72%(-37.8%) | -22.54%(-14.2%) |
| Sep 2021 | - | -26.27%(-6.4%) |
| Jun 2021 | - | -28.06%(-4.4%) |
| Mar 2021 | - | -29.36%(-2.9%) |
| Dec 2020 | -33.32%(-8.7%) | -30.24%(+10.7%) |
| Sep 2020 | - | -27.32%(-7.5%) |
| Jun 2020 | - | -29.52%(-16.1%) |
| Mar 2020 | - | -35.20%(-3.1%) |
| Dec 2019 | -36.51%(-43.1%) | -36.32%(+8.7%) |
| Sep 2019 | - | -33.41%(+15.9%) |
| Jun 2019 | - | -28.82%(-3.6%) |
| Mar 2019 | - | -29.89%(-60.1%) |
| Dec 2018 | -64.14%(+140.9%) | -74.88%(+20.6%) |
| Sep 2018 | - | -62.07%(+1.8%) |
| Jun 2018 | - | -60.98%(+5.6%) |
| Mar 2018 | - | -57.72%(+114.0%) |
| Dec 2017 | -26.62%(-25.4%) | -26.97%(-26.3%) |
| Sep 2017 | - | -36.58%(-5.4%) |
| Jun 2017 | - | -38.67%(-5.3%) |
| Mar 2017 | - | -40.84%(-1.8%) |
| Dec 2016 | -35.66%(-17.9%) | -41.57%(-2.3%) |
| Sep 2016 | - | -42.54%(+6.7%) |
| Jun 2016 | - | -39.87%(+8.0%) |
| Mar 2016 | - | -36.93%(+0.4%) |
| Dec 2015 | -43.44%(+9.5%) | -36.78%(-3.2%) |
| Sep 2015 | - | -37.98%(-0.2%) |
| Jun 2015 | - | -38.07%(-0.7%) |
| Mar 2015 | - | -38.33%(-3.7%) |
| Dec 2014 | -39.68%(+15.0%) | -39.81%(+4.1%) |
| Sep 2014 | - | -38.25%(-0.8%) |
| Jun 2014 | - | -38.56%(+3.9%) |
| Mar 2014 | - | -37.13%(-2.2%) |
| Dec 2013 | -34.51%(-34.8%) | -37.96%(-15.7%) |
| Sep 2013 | - | -45.04%(+4.1%) |
| Jun 2013 | - | -43.26%(+0.2%) |
| Mar 2013 | - | -43.19%(-12.0%) |
| Dec 2012 | -52.90%(+22.8%) | -49.09%(+4.4%) |
| Sep 2012 | - | -47.04%(+6.0%) |
| Jun 2012 | - | -44.36%(+1.9%) |
| Mar 2012 | - | -43.55%(+2.5%) |
| Dec 2011 | -43.09%(+2033.2%) | -42.48%(+388.8%) |
| Sep 2011 | - | -8.69%(+43.4%) |
| Jun 2011 | - | -6.06%(+14.6%) |
| Mar 2011 | - | -5.29%(+156.8%) |
| Dec 2010 | -2.02%(-94.2%) | -2.06%(-94.0%) |
| Sep 2010 | - | -34.40%(-5.6%) |
| Jun 2010 | - | -36.45%(-9.6%) |
| Mar 2010 | - | -40.34%(-16.9%) |
| Dec 2009 | -34.76%(-71.0%) | -48.55%(-1.5%) |
| Sep 2009 | - | -49.27%(+10.4%) |
| Jun 2009 | - | -44.62%(-8.4%) |
| Mar 2009 | - | -48.69%(-41.5%) |
| Dec 2008 | -120.00%(+182.0%) | -83.19%(-2.6%) |
| Sep 2008 | - | -85.44%(-3.7%) |
| Jun 2008 | - | -88.76%(+5.5%) |
| Mar 2008 | - | -84.13%(+143.2%) |
| Dec 2007 | -42.55%(+16.8%) | -34.60%(+29.9%) |
| Sep 2007 | - | -26.64%(-0.8%) |
| Jun 2007 | - | -26.85%(-8.6%) |
| Mar 2007 | - | -29.37%(+0.1%) |
| Dec 2006 | -36.42%(-17.2%) | -29.35%(-8.6%) |
| Sep 2006 | - | -32.12%(-1.5%) |
| Jun 2006 | - | -32.60%(-5.6%) |
| Mar 2006 | - | -34.54%(-21.0%) |
| Dec 2005 | -44.00% | -43.72%(+6.3%) |
| Sep 2005 | - | -41.11%(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2005 | - | -37.69%(+8.8%) |
| Mar 2005 | - | -34.63%(+17.7%) |
| Dec 2004 | -34.25%(-10.1%) | -29.41%(-6.9%) |
| Sep 2004 | - | -31.60%(+4.1%) |
| Jun 2004 | - | -30.36%(-2.8%) |
| Mar 2004 | - | -31.23%(-19.9%) |
| Dec 2003 | -38.08%(+22.1%) | -38.98%(+9.1%) |
| Sep 2003 | - | -35.72%(+22.8%) |
| Jun 2003 | - | -29.09%(-7.1%) |
| Mar 2003 | - | -31.33%(-1.5%) |
| Dec 2002 | -31.18%(-19.8%) | -31.81%(-15.4%) |
| Sep 2002 | - | -37.62%(-20.9%) |
| Jun 2002 | - | -47.57%(+4.3%) |
| Mar 2002 | - | -45.63%(+10.4%) |
| Dec 2001 | -38.88%(-26.2%) | -41.35%(-22.5%) |
| Sep 2001 | - | -53.35%(-0.3%) |
| Jun 2001 | - | -53.51%(-0.6%) |
| Mar 2001 | - | -53.84%(-10.1%) |
| Dec 2000 | -52.67%(-1.0%) | -59.92%(+42.0%) |
| Sep 2000 | - | -42.21%(-19.2%) |
| Jun 2000 | - | -52.22%(+1.2%) |
| Mar 2000 | - | -51.58%(-6.8%) |
| Dec 1999 | -53.18%(-83.3%) | -55.36%(+18.8%) |
| Sep 1999 | - | -46.58%(-83.9%) |
| Jun 1999 | - | -289.07%(-3.3%) |
| Mar 1999 | - | -298.82%(-8.9%) |
| Dec 1998 | -319.26%(+229.0%) | -328.06%(-12.8%) |
| Sep 1998 | - | -376.11%(+245.9%) |
| Jun 1998 | - | -108.73%(+5.8%) |
| Mar 1998 | - | -102.77%(+5.0%) |
| Dec 1997 | -97.04%(+60.4%) | -97.91%(+6.9%) |
| Sep 1997 | - | -91.62%(+69.1%) |
| Jun 1997 | - | -54.18%(-21.2%) |
| Mar 1997 | - | -68.73%(+4.4%) |
| Dec 1996 | -60.50%(+42.9%) | -65.82%(+17.0%) |
| Sep 1996 | - | -56.27%(-13.6%) |
| Jun 1996 | - | -65.16%(+32.3%) |
| Mar 1996 | - | -49.24%(-0.6%) |
| Dec 1995 | -42.35%(-1.8%) | -49.52%(-28.2%) |
| Sep 1995 | - | -68.98%(+18.7%) |
| Jun 1995 | - | -58.11%(+17.7%) |
| Mar 1995 | - | -49.39%(+17.2%) |
| Dec 1994 | -43.12%(+53.4%) | -42.15%(+20.3%) |
| Sep 1994 | - | -35.05%(+1.9%) |
| Jun 1994 | - | -34.38%(+4.2%) |
| Mar 1994 | - | -33.00%(-2.8%) |
| Dec 1993 | -28.11%(+92.9%) | -33.94%(+9.1%) |
| Sep 1993 | - | -31.10%(+32.9%) |
| Jun 1993 | - | -23.40%(+9.4%) |
| Mar 1993 | - | -21.38%(+39.5%) |
| Dec 1992 | -14.57%(-36.3%) | - |
| Oct 1992 | - | -15.33%(-5.3%) |
| Jul 1992 | - | -16.18%(-11.1%) |
| Apr 1992 | - | -18.20%(-0.5%) |
| Apr 1992 | -22.89%(-3.0%) | - |
| Jan 1992 | - | -18.29%(-20.7%) |
| Oct 1991 | - | -23.05%(+5.2%) |
| Jul 1991 | - | -21.92%(-9.5%) |
| Apr 1991 | -23.61%(+240.2%) | -24.22%(+51.5%) |
| Jan 1991 | - | -15.99%(+60.2%) |
| Oct 1990 | - | -9.98%(+1.2%) |
| Jul 1990 | - | -9.86%(+35.1%) |
| Apr 1990 | -6.94%(-17.4%) | -7.30%(-24.0%) |
| Jan 1990 | - | -9.60%(-25.5%) |
| Oct 1989 | - | -12.88%(+21.4%) |
| Jul 1989 | - | -10.61%(+27.4%) |
| Apr 1989 | -8.40%(-3.4%) | -8.33%(-27.8%) |
| Jan 1989 | - | -11.54%(+15.4%) |
| Oct 1988 | - | -10.00%(+18.2%) |
| Jul 1988 | - | -8.46%(-8.3%) |
| Apr 1988 | -8.70%(-3.2%) | -9.23%(+12.3%) |
| Jan 1988 | - | -8.22%(+20.0%) |
| Oct 1987 | - | -6.85%(+11.2%) |
| Jul 1987 | - | -6.16%(+12.4%) |
| Apr 1987 | -8.99%(-83.1%) | -5.48%(-94.8%) |
| Jan 1987 | - | -106.25%(-12.8%) |
| Oct 1986 | - | -121.88%(-7.1%) |
| Jul 1986 | - | -131.25%(0.0%) |
| Apr 1986 | -53.13% | -131.25% |
FAQ
- What is Celldex Therapeutics annual return on assets?
- What is the all time high annual ROA for Celldex Therapeutics?
- What is Celldex Therapeutics annual ROA year-on-year change?
- What is Celldex Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly ROA year-on-year change?
What is Celldex Therapeutics annual return on assets?
The current annual ROA of CLDX is -25.10%
What is the all time high annual ROA for Celldex Therapeutics?
Celldex Therapeutics all-time high annual return on assets is -2.02%
What is Celldex Therapeutics annual ROA year-on-year change?
Over the past year, CLDX annual return on assets has changed by +9.46% (+27.37%)
What is Celldex Therapeutics quarterly return on assets?
The current quarterly ROA of CLDX is -20.80%
What is the all time high quarterly ROA for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly return on assets is -2.06%
What is Celldex Therapeutics quarterly ROA year-on-year change?
Over the past year, CLDX quarterly return on assets has changed by 0.00% (0.00%)